Literature DB >> 8978308

Erythroblastic inclusions in dominantly inherited beta thalassemias.

P J Ho1, S N Wickramasinghe, D C Rees, M J Lee, A Eden, S L Thein.   

Abstract

While the precipitation of unstable variant beta-globin chains has been implicated as a major pathogenic mechanism in dominantly inherited beta thalassemia, their instability and presence in intra-erythroblastic inclusions have not been conclusively shown. We report the investigation of two cases of dominantly inherited beta thalassemia due to heterozygosity for the beta-codon 121 G-T mutation. In one case, we were able to demonstrate the presence of an abnormal beta-globin chain in both peripheral blood reticulocytes and bone marrow erythroblasts, and to assess its stability in relation to the substantial amounts of mutant beta mRNA transcript. The serum transferrin receptor (TfR) level was markedly increased, an indication of increased erythropoietic activity. In both cases, we could show by immunoelectron microscopy that the intra-erythroblastic inclusion bodies, a prominent feature of diseases in this category, contained not only precipitated alpha-globin chains, but also beta chains. The data confirm previous suggestions that the cellular pathology underlying this group of beta thalassemias is related to the synthesis of highly unstable beta-globin chain variants, which fail to form functional tetramers and precipitate intracellularly with the concomitant excess alpha chains, leading to increased ineffective erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8978308

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Protein quality control during erythropoiesis and hemoglobin synthesis.

Authors:  Eugene Khandros; Mitchell J Weiss
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  Dominantly inherited beta thalassaemia intermedia caused by a new single nucleotide deletion in exon 2 of the beta globin gene: Hb morgantown (beta91 CTG>CG).

Authors:  H-Y Luo; W Tang; S H Eung; J E Coad; P Canfield; F Keller; E H Crowell; M H Steinberg; D H K Chui
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 3.  Beta-thalassaemia prototype of a single gene disorder with multiple phenotypes.

Authors:  Swee Lay Thein
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 4.  Nonsense suppression therapies in human genetic diseases.

Authors:  Patrícia Martins-Dias; Luísa Romão
Journal:  Cell Mol Life Sci       Date:  2021-03-22       Impact factor: 9.261

5.  The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia.

Authors:  Christophe Lechauve; Julia Keith; Eugene Khandros; Stephanie Fowler; Kalin Mayberry; Abdullah Freiwan; Christopher S Thom; Paola Delbini; Emilio Boada Romero; Jingjing Zhang; Irene Motta; Heather Tillman; M Domenica Cappellini; Mondira Kundu; Mitchell J Weiss
Journal:  Sci Transl Med       Date:  2019-08-21       Impact factor: 17.956

Review 6.  The molecular basis of β-thalassemia.

Authors:  Swee Lay Thein
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

7.  Double heterozygocity for hemoglobin C and beta thalassemia dominant: A rare case of thalassemia intermedia.

Authors:  Alexandra Agapidou; Paul King; Cecilia Ng; Dimitris A Tsitsikas
Journal:  Hematol Rep       Date:  2018-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.